Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mimedx Group Inc
(NQ:
MDXG
)
9.220
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
9.220
Bid (Size)
8.870 (1)
Ask (Size)
9.450 (1)
Prev. Close
9.220
Today's Range
9.220 - 9.220
52wk Range
5.470 - 9.490
Shares Outstanding
111,946,829
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Thursday's Intraday Session
October 31, 2024
Via
Benzinga
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
July 17, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Performance
YTD
+17.15%
+17.15%
1 Month
+61.19%
+61.19%
3 Month
+40.12%
+40.12%
6 Month
+18.66%
+18.66%
1 Year
+21.80%
+21.80%
More News
Read More
Analyst Bullish On MiMedx's Rapid Growth In $4B Woundcare Market With Innovative Skin Substitutes
July 02, 2024
Via
Benzinga
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
Via
InvestorPlace
Mizuho Maintains Buy Rating for MiMedx Group: Here's What You Need To Know
March 01, 2024
Via
Benzinga
Recap: MiMedx Group Q4 Earnings
February 28, 2024
Via
Benzinga
MiMedx Group's Earnings: A Preview
October 27, 2023
Via
Benzinga
MDXG Stock Earnings: MiMedx Group Beats EPS, Beats Revenue for Q1 2024
April 30, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 28, 2024
Via
Benzinga
Get Rich Quick With These 3 Biotech Stocks to Buy Now
February 13, 2024
Via
InvestorPlace
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors to Inquire About Securities Class Action Investigation - MDXG
January 22, 2024
Via
NewMediaWire
Exposures
Product Safety
MDXG LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – MDXG
January 17, 2024
From
Rosen Law Firm
Via
Business Wire
MIMEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating MiMedx Group, Inc. on Behalf of MiMedx Stockholders and Encourages Investors to Contact the Firm
January 15, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
January 12, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
January 12, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
January 11, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
January 02, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday
October 27, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For October 30, 2023
October 30, 2023
Via
Benzinga
MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study
August 15, 2023
From
MediWound Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 01, 2023
Via
Benzinga
MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities
June 21, 2023
Via
Benzinga
MiMedx Group (NASDAQ: MDXG) Reports Q1 2023 Financial Results Showing 21.7% Sales Growth
May 03, 2023
Via
Spotlight Growth
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
March 03, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.